Table 1.
Subject demographic characteristics, lead information, and relevant medications taken or anesthesia delivered on the morning of the study. The time between delivery of medications or anesthesia and the start of the study are provided in parentheses. Asterisk (*) indicates that the subject underwent DBS lead implantation surgery.
| Subject | Age/Gender | Diagnosis | Medtronic Electrode | Mo. After Implant | Medications Taken Morning of Study (Approx. Delay from Delivery to Study Start Time) |
|---|---|---|---|---|---|
| EP12A | 65/M | ET | 3389 | 34 | None |
| EP12B | 73/M | ET | 3387 | 44 | None |
| EP12C | 68/M | PD | 3387 | 58 | None |
| EP12D | 73/F | ET | 3387 | 77 | None |
| EP12E | 76/M | PD | 3387 | 40 | None |
| EP13A | 72/M | ET | 3387 | 74 | Gabapentin, divalproex before surgery; fentanyl before/during surgery (>15 min) |
| EP13B* | 74/F | ET | 3389 | 0 | Primidone before surgery; fentanyl (80 min), midazolam (>50 min), dexmedetomidine (70 min) during surgery |
| EP13C* | 73/F | ET with mild Parkinsonism | 3389 | 0 | Primidone before surgery |
| EP13E* | 64/M | FXTAS | 3389 | 0 | Fentanyl during surgery (>15 min) |
| EP13F | 74/M | PD | 3387 | 90 | Isoflurane, dexmedetomidine during surgery (30 min) |
| EP13G* | 62/M | ET | 3389 | 0 | Propofol during surgery (45 min) |
| EP13H* | 66/M | ET | 3389 | 0 | Propofol during surgery (>40 min) |
| EP13I* | 70/F | ET | 3389 | 0 | Propofol (>30 min), fentanyl (>105 min) during surgery |
| EP13J* | 61/F | ET | 3389 | 0 | Fentanyl before surgery; midazolam (65 min), propofol (70 min) during surgery |
| EP13K | 71/M | ET | 3387 | 176 | Gabapentin before surgery |
| EP13L | 69/M | ET | 3389 | 74 | None |
| EP13N* | 69/F | ET | 3389 | 0 | Propofol during surgery (>50 min) |